ProfileGDS5678 / 1428584_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 11% 11% 10% 11% 21% 8% 9% 13% 11% 10% 10% 23% 10% 10% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.298711
GSM967853U87-EV human glioblastoma xenograft - Control 22.2655911
GSM967854U87-EV human glioblastoma xenograft - Control 32.2513310
GSM967855U87-EV human glioblastoma xenograft - Control 42.2400711
GSM967856U87-EV human glioblastoma xenograft - Control 52.452821
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.251998
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.253759
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2980713
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2478511
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2435810
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2388910
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5163923
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2555110
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2414710